Jacinto Convit World Organization Inc.
🇺🇸United States
A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
Phase 1
Not yet recruiting
- Conditions
- Metastatic Breast Cancer
- Interventions
- Biological: ConvitVax
- First Posted Date
- 2023-09-05
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- Jacinto Convit World Organization Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06023277
- Locations
- 🇺🇸
Jacinto Convit World Organization, Inc., Pompano Beach, Florida, United States
🇻🇪Fundación Jacinto Convit, Caracas, Miranda, Venezuela
🇻🇪Instituto de Oncología Dr. Luis Razetti, Caracas, Distrito Capital, Venezuela
© Copyright 2025. All Rights Reserved by MedPath